Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

LPAR1 anticorps (Extracellular)

Cet anticorps Lapin Polyclonal détecte spécifiquement LPAR1 dans WB, IHC, FACS et LCI. Il présente une réactivité envers Rat.
N° du produit ABIN7043311

Aperçu rapide pour LPAR1 anticorps (Extracellular) (ABIN7043311)

Antigène

Voir toutes LPAR1 Anticorps
LPAR1 (Lysophosphatidic Acid Receptor 1 (LPAR1))

Reactivité

  • 52
  • 21
  • 6
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
Rat

Hôte

  • 51
  • 4
Lapin

Clonalité

  • 48
  • 7
Polyclonal

Conjugué

  • 24
  • 4
  • 4
  • 4
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp LPAR1 est non-conjugé

Application

  • 38
  • 18
  • 13
  • 11
  • 11
  • 7
  • 4
  • 3
  • 3
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS), Live Cell Imaging (LCI)
  • Épitope

    • 15
    • 7
    • 5
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 36-50, Extracellular

    Fonction

    A Rabbit Polyclonal Antibody to LPA Receptor 1 (EDG2)

    Specificité

    Extracellular, N-terminus

     Réactivité croisée

    Humain, Souris, Rat

    Homologie

    Mouse - identical, human - 14,15 amino acid residues identical

    Attributs du produit

    Anti-LPAR1 (EDG2) (extracellular) Antibody (ABIN7043311, ABIN7044566 and ABIN7044567) is a highly specific antibody directed against an epitope of the rat LPA1 receptor. The antibody can be used in western blot analysis. It has been designed against an extracellular domain and thus is highly suitable for detecting the receptor in living cells. It has been designed to recognize LPA1 receptor from human, rat, and mouse samples.

    Purification

    Affinity purified on immobilized antigen.

    Immunogène

    Immunogen: Synthetic peptide

    Immunogen Sequence: (C)RSGKYLATEWNTVSK, corresponding to amino acid residues 36-50 of rat LPA1 receptor

    Isotype

    IgG
  • Indications d'application

    Antigen preadsorption control: 1 μg peptide per 1 μg antibody

    Application Dilutions Immunohistochemistry paraffin embedded sections ihc: 1:1000

    Application Dilutions Western blot wb: 1:400

    Commentaires

    Negative Control: (ABIN7235898)

    Blocking Peptide: (ABIN7235898)

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Recosntitute with double distilled water (DDW) to a concentration of 1.0 mg/mL.

    Concentration

    1 mg/mL

    Buffer

    PBS pH 7.4

    Stock

    4 °C,-20 °C

    Stockage commentaire

    Storage before reconstitution: The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.

    Storage after reconstitution: The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).

  • Antigène

    LPAR1 (Lysophosphatidic Acid Receptor 1 (LPAR1))

    Autre désignation

    LPAR1

    Sujet

    Lysophosphatidic acid receptor 1, LPA receptor 1, LPA-1, Gpcr91, Gpr26, VZG1,Lysophosphatidic acid is a naturally occurring lysophospholipid that activates diverse cellular actions in various cells including proliferation and morphological changes. There are currently three known genes that encode proteins of the LPA receptor family- Edg2, Edg4 and Edg7.Lysophosphatidic acid receptor 1 (also known as Lpa1), encoded by Edg2, belongs to G-coupled protein receptor (GPCR) superfamily. All three proteins share 50-54 % identical amino-acids. Lpa1 mostly activates the Gi pathway that leads to inhibition of adenylate cyclase and thus inhibition of cAMP production. Through this pathway, Lpa1 also initiates the Ras/MAP kinase cascade which is primarily responsible for increased cell proliferation1. Interestingly, binding of lysophosphatidic acid to the G13 G-protein activates the small GTP-binding protein Rho and induces the rapid remodeling of the actin cytoskeleton2.Lpa1 has been implicated in the pathogenesis of metastatic bone cancer. Silencing of Lpa1 expression in breast and ovarian cancer cells significantly alters the progression of bone metastasis through reduction of tumor burden and inhibition of bone resorption. A specific Lpa1 antagonist exhibits specificity for tumor cell-platelet interaction without abrogating normal platelet function3.

    Alternative names: LPAR1 (EDG2), Lysophosphatidic acid receptor 1, LPA receptor 1, LPA-1, Gpcr91, Gpr26, VZG1

    ID gène

    116744

    NCBI Accession

    NM_057159

    Pathways

    Myometrial Relaxation and Contraction, Smooth Muscle Cell Migration
Vous êtes ici:
Chat with us!